ORKA-001 — Clinical data readout
Q4 2026
The Company now expects to report Week 16 data for all participants in the fourth quarter of 2026.Source filing
ORKA biotech catalysts & pipeline
ORUKA THERAPEUTICS INC · Data as of 2026-10-25
Upcoming catalysts
ORKA-001 — Clinical data readout
Dec 2026
The Company also expects to report 52-week data from EVERLAST-A for all participants in December 2026.Source filing
ORKA-001 — Clinical data readout
2027
The Company also continues to advance the Phase 2b EVERLAST-B trial, with data expected in 2027.Source filing
ORKA-002 — Clinical data readout
Q1 2027
The Company now expects to report Week 16 data from ORCA-SURGE, a Phase 2 trial in moderate-to-severe PsO, in the first quarter of 2027.Source filing
ORKA-001 — Full data
Q3 2026
We plan to share Week 28 data from all patients at the end of the third quarter of 2026.Source filing